September 9, 2021
Via EDGAR
Securities and Exchange Commission
Division of Corporate Finance
Washington, D.C. 20549
Re: U.S. Stem Cell, Inc.
Offering Statement on Form 1-A
Filed August 30, 2021
File No. 024-11617
Ladies and Gentlemen:
On behalf of U.S. Stem Cell, Inc., a Florida corporation, I hereby request qualification of the above-referenced offering statement on Friday, September 10, 2021, at 3:00pm EST, or as soon thereafter as is practicable.
Please contact our securities counsel, Joseph I. Emas, at (305) 531-1174 or jiemas@josephiemaspa.com, should you have any questions regarding this request for qualification.
Sincerely,
/s/ Michael Tomas
Michael Tomas
Chief Executive Officer
1 | Page
1560 Sawgrass Corporate Pkwy, 4th FL
Sunrise, Florida 33323
(954) 835-1500